Drug Trial Radar · NCT01449513
PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy
Last checked: Nov 20, 2026Latest source record: Mar 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Sep 2011
Primary completion
May 2012
Study completion May 2012
Sponsor
- Lead sponsor
- LEO PharmaIndustry
- Sponsor type
- Industry
- First posted
- Oct 10, 2011
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial will be conducted to explore the biological effects in the skin following treatment with PEP005 Gel, 0.05% administered for two consecutive days, assessed by reflectance confocal microscopy.
Conditions
- Actinic Keratosis
Interventions
Ingenol mebutateDrug
0.05% Ingenol mebutate Gel once daily for 2 consecutive days
Placebo GelDrug
Gel vehicle of PEP005
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Degree of InfiltrationTime frame: Baseline to Day 2
- Change in Degree of InfiltrationTime frame: Baseline to Day 2
- Change in Degree of InfiltrationTime frame: Baseline to Day 2
- Change in Degree of InfiltrationTime frame: Baseline to Day 3
- Change in Degree of InfiltrationTime frame: Baseline to Day 3
- Change in Degree of InfiltrationTime frame: Baseline to Day 3
- Change in Degree of InfiltrationTime frame: Baseline to Day 8
- Change in Degree of InfiltrationTime frame: Baseline to Day 8
- Change in Degree of InfiltrationTime frame: Baseline to Day 8
- Change in Degree of InfiltrationTime frame: Baseline to Day 57
- Change in Degree of InfiltrationTime frame: Baseline to Day 57
- Change in Degree of InfiltrationTime frame: Baseline to Day 57
- Change in Degree of NecrosisTime frame: Baseline to Day 2
- Change in Degree of NecrosisTime frame: Baseline to Day 2
- Change in Degree of NecrosisTime frame: Baseline to Day 2
- Change in Degree of NecrosisTime frame: Baseline to Day 3
- Change in Degree of NecrosisTime frame: Baseline to Day 3
- Change in Degree of NecrosisTime frame: Baseline to Day 3
- Change in Degree of NecrosisTime frame: Baseline to Day 8
- Change in Degree of NecrosisTime frame: Baseline to Day 8
- Change in Degree of NecrosisTime frame: Baseline to Day 8
- Change in Degree of NecrosisTime frame: Baseline to Day 57
- Change in Degree of NecrosisTime frame: Baseline to Day 57
- Change in Degree of NecrosisTime frame: Baseline to Day 57
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Charité - Universitätsmedizin Berlin
Berlin, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.